HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Parker Selected Research

(7- (2- (4- difluorophenyl)- 1- piperazinyl)ethyl)- 2- (2- furanyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidin- 5- amine

9/2013A2A receptor antagonists do not induce dyskinesias in drug-naive or L-dopa sensitized rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Parker Research Topics

Disease

2Neoplasms (Cancer)
08/2014 - 02/2013
1Osteoarthritis
11/2020
1Asthma (Bronchial Asthma)
08/2014
1Dyskinesias (Dyskinesia)
09/2013
1Parkinson Disease (Parkinson's Disease)
09/2013
1Renal Cell Carcinoma (Grawitz Tumor)
01/2009
1Cysts
07/2007
1Erectile Dysfunction
12/2001
1Alzheimer Disease (Alzheimer's Disease)
04/2001
1Hemophilia A (Haemophilia)
01/2001

Drug/Important Bio-Agent (IBA)

24-dichlorobenzene (1,4-dichlorobenzene)IBA
08/2014 - 02/2013
1PlectinIBA
11/2020
1Volatile Organic CompoundsIBA
08/2014
1naphthaleneIBA
08/2014
1Benzene (Benzole)IBA
08/2014
1CarcinogensIBA
08/2014
1istradefyllineIBA
09/2013
1Levodopa (L Dopa)FDA LinkGeneric
09/2013
1Caffeine (No Doz)FDA LinkGeneric
09/2013
1(7- (2- (4- difluorophenyl)- 1- piperazinyl)ethyl)- 2- (2- furanyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidin- 5- amineIBA
09/2013
1Dopamine Receptors (Dopamine Receptor)IBA
09/2013
1Dopamine (Intropin)FDA LinkGeneric
09/2013
1antineoplaston A10 (A 10)IBA
02/2013
1EpitopesIBA
01/2009
1Hormones (Hormone)IBA
07/2007
1Insulin (Novolin)FDA Link
07/2007
1melanotan-IIIBA
12/2001
1Gamma Secretase Inhibitors and ModulatorsIBA
04/2001
1Factor VIII (Coagulation Factor VIII)IBA
01/2001
1Factor VII (Proconvertin)IBA
01/2001

Therapy/Procedure

1Therapeutics
04/2001
1Intravenous Injections
01/2001